DENTSPLY SIRONA (NASDAQ:XRAY) Stock Gets Price Target Trim from UBS Group

DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) had its price target reduced by UBS Group from $17.00 to $13.00 in a research note published on Monday morning,Benzinga reports. UBS Group currently has a buy rating on the medical instruments supplier’s stock.

A number of other research analysts have also recently issued reports on the stock. Barrington Research cut their target price on shares of DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating for the company in a research note on Monday, October 26th. BMO Capital Markets decreased their price target on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a research report on Thursday, September 17th. Barclays increased their price target on DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research report on Monday, August 24th. Zacks Research cut DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 9th. Finally, JPMorgan Chase & Co. cut their price objective on DENTSPLY SIRONA from $12.00 to $10.00 and set a “neutral” rating for the company in a research report on Friday, November 6th. Three analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Reduce” and a consensus price target of $12.08.

Check Out Our Latest Analysis on XRAY

DENTSPLY SIRONA Stock Down 0.9%

XRAY opened at $8.52 on Monday. The firm has a market cap of $1.69 billion, a price-to-earnings ratio of 6.37, a PEG ratio of 1.26 and a beta of 0.87. The company has a debt-to-equity ratio of 1.47, a quick ratio of 1.04 and a current ratio of 1.63. The firm’s 50-day simple moving average is $9.29 and its 200-day simple moving average is $11.14. DENTSPLY SIRONA has a twelve month low of $8.14 and a twelve month high of $14.76.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.31 by ($0.02). The firm had revenue of $836.00 million for the quarter, compared to the consensus estimate of $861.68 million. DENTSPLY SIRONA had a negative net margin of 3.38% and a positive return on equity of 20.21%. The company’s revenue for the quarter was down 7.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.37 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. Equities research analysts anticipate that DENTSPLY SIRONA will post 1.21 EPS for the current fiscal year.

Institutional Trading of DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in XRAY. BlackRock Inc. acquired a new position in DENTSPLY SIRONA during the 2nd quarter valued at about $283,405,000. Southpoint Capital Advisors LP bought a new stake in shares of DENTSPLY SIRONA during the first quarter worth approximately $116,000,000. Edmond DE Rothschild Holding S.A. bought a new stake in shares of DENTSPLY SIRONA during the second quarter worth approximately $47,780,000. Dimensional Fund Advisors LP raised its stake in shares of DENTSPLY SIRONA by 31.4% during the first quarter. Dimensional Fund Advisors LP now owns 3,559,388 shares of the medical instruments supplier’s stock worth $41,284,000 after buying an additional 850,261 shares during the last quarter. Finally, Paradigm Capital Management Inc. NY acquired a new position in DENTSPLY SIRONA in the second quarter valued at approximately $39,775,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

(Get Free Report)

DENTSPLY SIRONA Inc. develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care. The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.

Further Reading

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.